Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan-Dec:12:23247096231220467.
doi: 10.1177/23247096231220467.

Peritoneal Dialysis-Associated Peritonitis Caused by Achromobacter xylosoxidans: A Case Report and Literature Review

Affiliations
Review

Peritoneal Dialysis-Associated Peritonitis Caused by Achromobacter xylosoxidans: A Case Report and Literature Review

Ibrahim Tawhari et al. J Investig Med High Impact Case Rep. 2024 Jan-Dec.

Abstract

Achromobacter xylosoxidans is a gram-negative bacterium that is responsible for rare peritonitis associated with peritoneal dialysis (PD). We present a case of a 64-year-old woman with a medical history of end-stage renal disease undergoing PD who was admitted to the emergency department with abdominal pain and nausea. Physical examination and laboratory studies revealed peritoneal signs and laboratory abnormalities consistent with peritonitis. Intraperitoneal catheter dysfunction was identified and subsequently resolved via laparoscopy. Following a peritoneal fluid culture, A xylosoxidans was identified, leading to the initiation of intraperitoneal meropenem treatment. After an initial improvement, the patient developed an ileus and recurrent abdominal symptoms, and further peritoneal cultures remained positive for A xylosoxidans. Subsequent treatment included intravenous meropenem and vancomycin for Clostridium difficile colitis. Owing to the high likelihood of biofilm formation on the PD catheter by A xylosoxidans, the catheter was removed, and the patient transitioned to hemodialysis. Intravenous meropenem was continued for 2 weeks post-catheter removal. This case highlights the challenges in managing recurrent peritonitis in PD patients caused by multidrug-resistant A xylosoxidans. A high index of suspicion, appropriate microbiological identification, and targeted intraperitoneal and systemic antibiotic treatment, along with catheter management, are crucial in achieving a favorable outcome in such cases.

Keywords: A xylosoxidans; Achromobacter xylosoxidans infection; peritoneal dialysis; peritonitis; tunnel infection.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Kim HJ, Park HS, Bae E, et al.. A Case of peritoneal dialysis-related peritonitis caused by Aeromonas hydrophila in the patient receiving automated peritoneal dialysis. Electrolyte Blood Press. 2018;16(2):27-29. doi:10.5049/EBP.2018.16.2.27 - DOI - PMC - PubMed
    1. Donderski R, Grajewska M, Mikucka A, Sulikowska B, Gospodarek-Komkowska E, Manitius J. Achromobacter xylosoxidans relapsing peritonitis and Streptococcus suis peritonitis in peritoneal dialysis patients: a report of two cases. Case Rep Nephrol. 2018;2018:9454520. doi:10.1155/2018/9454520 - DOI - PMC - PubMed
    1. Al Sahlawi M, Zhao J, McCullough K, et al.. Variation in peritoneal dialysis–related peritonitis outcomes in the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis. 2022;79(1):45-55. doi:10.1053/j.ajkd.2021.03.022 - DOI - PubMed
    1. Perl J, Fuller DS, Bieber BA, et al.. Peritoneal dialysis–related infection rates and outcomes: results from the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis. 2020;76(1):42-53. doi:10.1053/j.ajkd.2019.09.016 - DOI - PubMed
    1. Alfayez SM, Alsaqoub SM, Qattan AY, et al.. Peritoneal dialysis related infections in a Tertiary Care Hospital in Riyadh, Saudi Arabia. Saudi Med J. 2019;40(2):147-151. doi:10.15537/smj.2019.2.23898 - DOI - PMC - PubMed

LinkOut - more resources